2019 annual financial data
China SXT Pharmaceuticals 2019 Operating margin
Direct answer
Operating margin was 25.24%.
Operating income was 1,769,492 USD and net income was 1,539,227 USD.
Operating cash flow was 239,192 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,012,026 USD
- Operating income
- 1,769,492 USD
- Net income
- 1,539,227 USD
- Operating cash flow
- 239,192 USD